National Healthcare Agreement: PI 24–Survival of people diagnosed with notifiable cancers, 2021
Indicator Attributes
Identifying and definitional attributes | |
Metadata item type:![]() | Indicator |
---|---|
Indicator type:![]() | Progress measure |
Short name:![]() | PI 24–Survival of people diagnosed with cancers, 2021 |
METEOR identifier:![]() | 725775 |
Registration status:![]() | Health, Standard 16/09/2020 |
Description:![]() | Five-year relative survival proportions for people diagnosed with cancer. |
Indicator set:![]() | National Healthcare Agreement (2021) Health, Standard 19/11/2020 |
Outcome area:![]() | Hospital and Related Care Health, Standard 07/07/2010 National Health Performance Authority (retired), Retired 01/07/2016 |
Collection and usage attributes | |
Computation description:![]() | The probability of surviving 5 years in people with cancer is divided by the probability of surviving 5 years in the general population (matched on age, sex and calendar year). Analysis will be undertaken using the ‘period’ method of calculation. See Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Presented as a percentage. |
---|---|
Computation:![]() | 100 x (Numerator ÷ Denominator) |
Numerator:![]() | Probability of surviving for 5 years in the people diagnosed with cancer. |
Numerator data elements:![]() | |
Denominator:![]() | Probability of surviving for 5 years in the general population |
Denominator data elements:![]() | |
Disaggregation:![]() | 2012–16 and 2013–17 — Nationally, by:
'All cancers combined' comprises ICD-10 (2016 version) codes C00–C97, D45–D46, D47.1 and D47.3–D47.5, except basal and squamous cell carcinomas of the skin (part of C44). The ICD-10 codes for the other cancer types are as follows: bowel cancer C18–C20, lung cancer C33–C34, melanoma of the skin C43, female breast cancer C50 and cervical cancer C53. |
Disaggregation data elements:![]() | |
Comments:![]() | Most recent data available for 2021 National Healthcare Agreement performance reporting: 2013–17. |
Representational attributes | |
Representation class:![]() | Percentage |
Data type:![]() | Real |
Unit of measure:![]() | Person |
Format:![]() | N[NN].N |
Indicator conceptual framework | |
Framework and dimensions:![]() | Effectiveness |
Data source attributes | |
Data sources:![]() | |
Accountability attributes | |
Reporting requirements:![]() | National Healthcare Agreement |
Organisation responsible for providing data:![]() | Australian Institute of Health and Welfare |
Further data development / collection required:![]() | Specification: Final, the measure meets the intention of the indicator. |
Source and reference attributes | |
Reference documents:![]() | AIHW (Australian Institute of Health and Welfare) 2012. Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Cancer series no. 69. Cat. no. CAN 65. Canberra: AIHW. Viewed 7 November 2019, |
Relational attributes | |
Related metadata references:![]() | Supersedes National Healthcare Agreement: PI 24–Survival of people diagnosed with notifiable cancers, 2020 Health, Standard 13/03/2020 Has been superseded by National Healthcare Agreement: PI 24–Survival of people diagnosed with notifiable cancers, 2022 Health, Standard 24/09/2021 See also Australian Health Performance Framework: PI 2.1.5–Survival of people diagnosed with cancer, 2019 Health, Superseded 01/12/2020 See also National Healthcare Agreement: PI 02–Incidence of selected cancers, 2021 Health, Standard 16/09/2020 |